Skip to main content

Publisher: Bentham Science Publishers

More about this publication?
Volume 1, Number 4, 2005

Review article

Modelling of Aldose Reductase Inhibitory Activity of Pyrrol-1-yl-acetic Acid Derivatives by Means of Multivariate Statistics
pp. 321-326(6)
Authors: Tsantili-Kakoulidou, A.; Nicolaou, I.; Vrakas, D.; Demopoulos, V. J.

Favourites:
ADD

Bangladeshi Medicinal Plant Extracts Inhibiting Molecular Interactions between Nuclear Factors and Target DNA Sequences Mimicking NF-kB Binding Sites
pp. 327-333(7)
Authors: Lampronti, I.; Khan, M. T.H.; Bianchi, N.; Ather, A.; Borgatti, M.; Vizziello, L.; Fabbri, E.; Gambari, R.

Favourites:
ADD

Synthesis, Structure-Activity Relationships and Antagonistic Effects in Human MCF-7 Breast Cancer Cells of Flexible Estrogen Receptor Modulators
pp. 335-353(19)
Authors: Lloyd, David G.; Smith, Helena M.; O'Sullivan, Timothy; Zisterer, Daniela M.; Meegan, Mary J.

Favourites:
ADD

Computational Insight into Anti-mutagenic Properties of CYP1A Flavonoid Ligands
pp. 355-360(6)
Authors: Fonseca, Rute d.; Marini, Michele; Melo, Andre; Menziani, Maria Cristina; Ramos, Maria Joao

Favourites:
ADD

New non-peptidic Inhibitors of Papain Derived from Etacrynic Acid
pp. 361-370(10)
Authors: Kaeppler, U.; Schirmeister, T.

Favourites:
ADD

QSAR of the Anticonvulsant Enaminones; Molecular Modeling Aspects and other Assessments
pp. 371-381(11)
Authors: Wilson, T. L.; Jackson, P. L.; Hanson, C. D.; Xue, Z.; Eddington, N. D.; Scott, K. R.

Favourites:
ADD

Topoisomerase Enzymes as Therapeutic Targets for Cancer Chemotherapy
pp. 383-394(12)
Authors: Giles, Gregory I.; Sharma, Ram P.

Favourites:
ADD

Role of Prostaglandin E Receptor Subtypes in Gastroduodenal HCO3 - Secretion
pp. 395-403(9)
Authors: Takeuchi, Koji; Aihara, Eitaro; Hayashi, Masamune; Sasaki, Yoko

Favourites:
ADD

GPCR Agonists and Antagonists in the Clinic
pp. 405-421(17)
Authors: Tyndall, Joel D. A.; Sandilya, Radhika

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content